AATHEN - The UBC Advanced Angiotensin Therapeutics Network

Angiotensin receptor blockers are well-established anti-hypertensive medications with a long list of therapeutic effects in non-blood pressure-related diseases. The multi-Centre, tri-Faculty UBC Advanced Angiotensin Therapeutics Network (AATHEN) was created to facilitate collaborations aimed at optimizing the pleiotropic properties of angiotensin receptor blockers and develop non-blood pressure lowering analog compounds.